This drug has one hundred and nine patent family members in thirty-one countries.
The generic ingredient in ATRIPLA is efavirenz; emtricitabine; tenofovir disoproxil fumarate. Five suppliers are listed for this compound. Additional details are available on the efavirenz; emtricitabine; tenofovir disoproxil fumarate profile page.
Copyright © DrugPatentWatch. Originally published at New patent expiration for Gilead Sciences drug ATRIPLA